Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque

Atherosclerosis

Volumn 105, Issue 1, 1994, Pages 1-7

  Rabbani, LeRoy E ^a   Loscalzo, Joseph ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Fibrinogen; Lipoprotein(a); Platelets

Indexed keywords

FIBRINOGEN; LIPOPROTEIN A;

ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; FOAM CELL; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE;

ARTERIOSCLEROSIS; BLOOD COAGULATION; BLOOD PLATELETS; FIBRINOGEN; FIBRINOLYSIS; FOAM CELLS; HEMOSTASIS; HUMAN; LIPOPROTEIN(A); SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; THROMBIN; THROMBOSIS;

EID: 0027979451     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(94)90002-7     Document Type: Review

References (66)

1. Fibrinolysis and atherosclerosis
2. Thrombosis as a factor in the pathogenesis of coronary atherosclerosis
3. Atherosclerotic metamorphosis of autologous pulmonary thromboemboli in the rabbit.
4. Studies of hypercholesterolemia in the nonhuman primate, I. Changes that lead to fatty streak formation
5. Platelet-mediated cholesterol accumulation in cultured aortic smooth muscle cells
6. Role of platelets in cholesteryl ester formation by U-937 cells
7. Isolation and characterization of lipid-protein particles containing platelet factor-3 released from human platelets
8. Direct detection of activated platelets and plateletderived microparticles in humans
9. New mechanisms for foam cell generation in atherosclerotic lesions
10. Platelet secreted lipoprotein-like particles enhance macrophage cholesterol accumulation
11. Thrombosis and the development of atherosclerosis: Rokitansky revisited
12. The incorporation of fibrin in the aortic intima
13. Fatty streaks in the aortic intima studied by an immunohistochemical technique
14. The distribution of fibrin within the aortic intima, An immunohistochemical study
15. Demonstration of fibrin in yellow aortic streaks by the fluorescent antibody technique
16. Electron microscopy of fibrin in human atherosclerotic lesions. Immunohistochemical and morphologic identification
17. Histological and immunofluorescent studies on the evolution of the human atherosclerotic plaque
18. Infiltration and thrombosis in atherogenesis, A study using immunofluorescent techniques
19. Immunochemical characterization of fibrinogen, fibrin I and fibrin II in human thrombi and atherosclerotic lesions
20. Identification and distribution of fibrinogen, fibrin and fibrin(ogen) degradation products in atherosclerosis: Use of monoclonal antibodies
21. Fate of fibrinogen in human arterial intima
22. Visualization of apo B, fibrinogen/fibrin and fibronectin in the intima of normal human aorta and larger arteries and during atherosclerosis
23. Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture
24. Effects of fibrinogen and fibrin on the migration of vascular smooth muscle cells in vitro
25. Defibrinogenation by Arvin reduces air-drying-induced arteriosclerosis in rat carotid artery
26. The effects of fibrin on cultured vascular endothelial cells
27. Endothelial injury induced by thrombin on thrombi
28. Interaction between fibrinogen and cultured endothelial cells: Induction of migration and specific binding
29. Effects of fibrinogen derviatives upon the inflammatory response
30. Effect of fibrin on endothelial cell production of prostacyclin and tissue plasminogen activator
31. Fibrin-mediated vascular injury: Identification of fibrin peptides that mediate endothelial cell retraction
32. Disorganization of cultured vascular endothelial cell monolayers by fibrinogen fragment D
33. 2 synthesis by cultured porcine aortic endothelial and smooth muscle cells
34. Atherosclerosis and the coagulation system
35. The relationship between atherosclerosis and thrombosis
36. Thrombotic determinants of macrophage foam-cell formation
37. Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition-specificity for fibrinogen
38. Thrombin and factor Xa enhance the production of interleukin-1
39. Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth factor inhibitory prostanoids
40. Induction by IL-1 and interferongamma: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1)
41. Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture
42. Plasminogen activator inhibitors
43. Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells
44. Lipoprotein(a): A unique risk factor for atherothrombotic disease
45. Lipoprotein(a) and atherosclerosis
46. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen
47. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen
48. Lipoprotein(a) and the risk for myocardial infarction
49. Assocation of levels of lipoprotein(a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography
50. Lipiprotein(a), fibrin binding and plasminogen activation
51. Plasmin catalyzes binding of lipoprotein(a) to immobilized fibrinogen and fibrin
52. Lipoprotein(a) modulation of endothelial surface fibrinolysis and its potential role in atherosclerosis
53. A potential basis for the thrombotic risks associated with lipoprotein(a)
54. Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation
55. Tissue-type plasminogen activator binds to and is inhibited by lipoprotein(a) and low density lipoprotein
56. Lipoprotein(a) regulates plasminogen activator inhibitor-1 expression in endothelial cells: A potential mechanism for thrombogenesis
57. Modification of Lp(a) by malondialdehyde leads to avid uptake by human monocyte/macrophages
58. Uptake of Lp(a) by cultured fibroblasts
59. Studies on the role of specific cell surface receptors in the removal of lipoprotein(a) in man
60. Lipoprotein(a) in the arterial wall
61. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoproprotein, II, Preferential immobilization of lipoprotein(a) Lp(a)
62. Lipoprotein (a) accumulates intracellularly in coronary atherectomy specimens obtained from primary and restenotic lesions after PTCA
63. Lipoprotein(a) inhibits fibrinogen uptake and degradation by mononuclear cells
64. Proliferation of human smoth muscle cell promoted by lipoprotein(a)